Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 17, 2007, doi:10.1212/01.wnl.0000254991.21818.f3)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000254991.21818.f3v1
68/8/578    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deak, K. L.
Right arrow Articles by Gilbert, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deak, K. L.
Right arrow Articles by Gilbert, J. R.
Related Collections
Right arrow Muscle disease
Right arrow All Genetics
NEUROLOGY 2007;68:578-582
© 2007 American Academy of Neurology

Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4

K. L. Deak, PhD, R. J.L.F Lemmers, PhD, J. M. Stajich, PA, R. Klooster, PhD, R. Tawil, MD, R. R. Frants, PhD, M. C. Speer, PhD, S. M. van der Maarel, PhD and J. R. Gilbert, PhD

From the Center for Human Genetics (K.L.D., J.M.S., M.C.S., J.R.G.), Duke University Medical Center, Durham, NC; Center for Human and Clinical Genetics (R.J.L.F.L., R.K., R.R.F., S.M.vdM.), Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology (R.T.), University of Rochester, Rochester, NY.

Address correspondence and reprint requests to Dr. John R. Gilbert, Duke University Medical Center, Box 3445, Durham, NC 27710; e-mail: john{at}chg.duhs.duke.edu

Background: In the majority of facioscapulohumeral muscular dystrophy (FSHD) cases, the molecular basis of the disease is due to loss of subtelomeric D4Z4 repeat units at 4q35. Occasionally, an apparent absence of the contracted D4Z4 repeat is associated with FSHD. One explanation for this finding is a deletion in the region proximal to the D4Z4 repeat array that encompasses the p13E-11 (D4F104S1) probe-binding site used in the DNA diagnosis. The frequency of such proximally extended deletions is unknown, and to date, few patients have been described due to the difficulties in the molecular identification of such cases.

Methods: We describe a family (DUK 2531) in which a contracted D4Z4 allele and a large proximal deletion of approximately 75 kb are segregating to 11 individuals. This is the largest deletion identified to date. Family DUK 2531 was initially thought to have normal D4Z4 fragment size and therefore unlinked to the 4q35 region (FSHD1B).

Results: Further molecular analysis of DUK 2531 reveals the presence of 10 repeat units (33 kb). The extended deletion includes the probe p13E-11 and B31 binding sites, the inverted repeat D4S2463, and genes FRG2 and TUBB4Q.

Conclusion: Despite the length of the proximal deletion in this family, the range and severity of the clinical manifestations are typical for the disorder. Because such deletions can lead to misinterpretation in the diagnostic setting, this suggests the need for additional diagnostic tests in facioscapulohumeral muscular dystrophy.


Editorial, see page 544

See also page 569

This article was previously published in electronic format as an Expedited E-Pub on January 17, 2007, at www.neurology.org.

Supported by grants from the FSH Society, the Muscular Dystrophy Association (United States), and the Shaw family (The Netherlands). R.T. is supported by the University of Rochester Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (AR050762).

Disclosure: The authors report no conflicts of interest.

Received February 1, 2006. Accepted in final form November 27, 2006.


Related articles in Neurology:

February 20 Highlights

Neurology 2007 68: 540-541. [Full Text]  

Pushing the genetic frontier with facioscapulohumeral muscular dystrophy
Steven A. Greenberg and George W. Padberg
Neurology 2007 68: 544-545. [Full Text]  

Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy
R. J. Osborne, S. Welle, S. L. Venance, C. A. Thornton, and R. Tawil
Neurology 2007 68: 569-577. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
K. Tsumagari, L. Qi, K. Jackson, C. Shao, M. Lacey, J. Sowden, R. Tawil, V. Vedanarayanan, and M. Ehrlich
Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers
Nucleic Acids Res., April 1, 2008; 36(7): 2196 - 2207.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. A. Greenberg and G. W. Padberg
Pushing the genetic frontier with facioscapulohumeral muscular dystrophy
Neurology, February 20, 2007; 68(8): 544 - 545.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.